🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas L. Ekstrom

Robert Bosch Hospital

ORCID: 0000-0002-9363-2984

Also affiliated with Mayo Clinic in Arizona

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases”.

VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-1099

N/A

0DataRank · unranked

38 citations

Nicholas M. Pathoulas, Amelia M. Huehls, Arun Kanakkanthara, Larry M. Karnitz, Thomas L. Ekstrom

Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer

Gut(2023)10.1136/gutjnl-2022-328154

N/A

0DataRank · unranked

16 citations

Amro M. Abdelrahman, Ana P. Kutschat, Xin Wang, Thomas L. Ekstrom, Nidhi Jalan‐Sakrikar +19 more

KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.30.662301

N/A

0DataRank · unranked

1 citations

Zhangshuai Dai, Julia Thiel, Meghana Manjunath, not provided Joseph Schacherer, Bishakha Joyeeta Saha +8 more